ClinicalTrials.gg
RecruitingNCT07493018Updated Nov 16, 2026

Effect of Hand Puppet and Squeeze Toys on IV Placement in Pediatric Oncology Patients

An interventional study of Performing a Hand Puppet to Music and Hand Squeezing Soft Toy (Squishy) in Pediatric Hematology and Pediatric Oncology, sponsored by Akdeniz University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Akdeniz University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Updated Nov 16, 2026Now RecruitingFirst site in Turkey (Türkiye)+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
6 Years to 10 Years
Sex
All
01

Study summary

This randomized controlled trial investigates hand puppet and squeeze toy techniques to reduce fear, emotional distress, and procedure time, and improve IV catheter placement success in 90 pediatric hematology-oncology patients (ages 6-10). Participants will be randomized into three groups: hand puppet, squeeze toy, or control. Outcomes include fear, emotional expression, procedure duration, number of attempts, and first-attempt success.

02

Conditions studied

  • Pediatric Hematology
  • Pediatric Oncology
03

In context

Lead sponsor

Akdeniz University is the lead sponsor of 298 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Children aged 6-10 years with a pediatric hematology or oncology diagnosis.

Cognitively able to understand instructions during the procedure.

Require peripheral IV catheter placement as determined by the healthcare team.

Difficult Intravenous Access (DIVA) Score ≥4.

Child and parent/guardian willing to participate.

Exclusion criteria

Exclusion Criteria:

Physical condition preventing use of a squeeze toy.

Cognitive or developmental disorders preventing understanding of procedural instructions.

-

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Hand Puppet

    In this arm, an independent researcher will use a hand puppet with child-friendly animal or profession-themed designs, moving it to music during IV catheter placement to engage the child's attention. The child selects the puppet and interacts with it while another researcher collects data. This distraction aims to reduce fear, negative emotional responses, number of IV attempts, and procedure duration.

    Other: Performing a Hand Puppet to Music

  • Experimental
    Squeeze Toy

    Children will receive a soft, colorful squeeze toy in their non-procedure hand during IV catheter placement. They will be encouraged to rhythmically squeeze and release the toy, which engages their attention. This distraction aims to reduce fear, negative emotional responses, number of IV attempts, and procedure duration.

    Other: Hand Squeezing Soft Toy (Squishy)

  • No intervention
    Control

    Children in the control group will receive standard peripheral IV catheter placement without any distraction techniques.

Interventions

  • OtherPerforming a Hand Puppet to Music

    Children interact with a hand puppet chosen according to their preference during IV catheter placement. The puppet's playful movements and music aim to distract and reduce fear and emotional distress.

  • OtherHand Squeezing Soft Toy (Squishy)

    Children will receive a soft, colorful squeeze toy in their non-procedure hand during IV catheter placement. They will be encouraged to rhythmically squeeze and release the toy, which engages their attention, reduces fear and distress, and helps them keep the procedure hand still. The toy is chosen by the child, hygienically managed, and given as a gift afterward. This simple, low-cost intervention aims to improve cooperation and IV placement success.

06

What researchers measure

Primary outcomes

  1. Procedure duration

    Time from start to successful IV catheter placement.

    Time frame: During procedure

  2. Number of IV catheter attempts:

    Recorded for each peripheral IV catheter placement.

    Time frame: During the IV procedure

Secondary outcomes

  1. Children's Fear Scale

    A 5-point visual scale (0 = no fear, 4 = extreme fear) measuring children's anxiety and fear before and after the procedure. Applicable for children aged 5-10, can be completed by the child or observer.

    Time frame: Measured before and immediately after IV catheter placement

  2. Children's Emotional Manifestation Scale

    Observational tool evaluating emotional responses during stressful medical procedures across five categories (facial expression, vocalization, activity, interaction, cooperation). Each category scored 1-5; total score 5-25, with higher scores indicating more negative emotional responses.

    Time frame: During procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Gurcan M, Karatas N, Kaya A, Turan SA, Guler E. The effect of a pushing technique with normal saline on peripheral intravenous catheter placement success in paediatric haematology and oncology: A randomized controlled trial. Eur J Oncol Nurs. 2024 Aug;71:102656. doi: 10.1016/j.ejon.2024.102656. Epub 2024 Jul 2. PubMed 39002409 ↗
  • Gerceker GO, Bektas I, Yardimci F. The effects of virtual reality and stress ball distraction on procedure-related emotional appearance, pain, fear, and anxiety during phlebotomy in children: A randomized controlled study. J Pediatr Nurs. 2024 Nov-Dec;79:197-204. doi: 10.1016/j.pedn.2024.08.029. Epub 2024 Sep 17. PubMed 39293201 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started May 2026 (actual). Primary completion is estimated for Dec 2026, 7 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Oct 2026 → Dec 2026 and completion Oct 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2026
First posted
Mar 25, 2026
StartActual
May 1, 2026
Primary completionEst.
Dec 2026was Oct 2026
CompletionEst.
Dec 2026was Oct 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 16, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Akdeniz University Hospital · Antalya, Turkey (Türkiye)
Nov 16, 2026
Primary completion
Oct 2026→Dec 2026
Nov 16, 2026
Study completion
Oct 2026→Dec 2026
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Akdeniz University Hospital · Antalya, Turkey (Türkiye)
    Primary completion Oct 2026→Dec 2026
    Study completion Oct 2026→Dec 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07493018
Lead sponsor
Akdeniz University
Responsible party
Meltem Gürcan (PhD, Research Assistant, Akdeniz University) — Principal investigator
First posted
Mar 25, 2026
Start date
May 1, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 16, 2026

Study contacts

Meltem Gürcan, PhD
Contact
meltemgurcan32@gmail.com
+90 506 508 6214

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion